ARCT

ARCT Stock-Based Compensation

$21.10MTTM · USD

Period ending:

ARCT FY Stock-Based CompUSD
ARCT FY Stock-Based Comp2011-12-31: $1.55M2012-12-31: $26.00K2013-12-31: $1.54M2014-12-31: $4.09M2015-12-31: $2.37M2016-12-31: $2.50M2017-12-31: $2.17M2018-12-31: $1.26M2019-12-31: $1.98M2020-12-31: $6.76M2021-12-31: $28.92M2022-12-31: $30.61M2023-12-31: $34.65M2024-12-31: $37.99M2025-12-31: $25.41M$37.99M$0.00
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ARCT stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Arcturus Therapeutics Holdings Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
25,408,000
37,988,000
34,649,000
30,611,000
28,915,000
6,764,000
1,982,000
1,259,000
2,170,000
2,500,000
2,365,000
4,089,000
1,540,000
26,000
1,553,000

Compare stock-based compensation

All ARCT financial metrics · ARCT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.